Skip to content

Myriad Genetics MYGN Income Statement

FY'25FY'24FY'23FY'22
$824.5M-1.6%$837.6M+11.2%$753.2M+11.0%$678.4M-1.8%
$247.9M-1.7%$252.2M+6.8%$236.2M+16.9%$202M
$576.6M-1.5%$585.4M+13.2%$517M+8.5%$476.4M
69.9%0.0pp69.9%+1.2pp68.6%-1.6pp70.2%
$106.8M-5.2%$112.7M+27.1%$88.7M+3.9%$85.4M+4.3%
$280.8M-1.2%$284.1M-1.8%$289.2M+8.4%$266.8M
$256.8M-7.1%$276.5M-2.5%$283.7M+14.4%$247.9M
$963.8M+36.0%$708.8M-8.5%$774.4M+25.5%$617M
-$387.2M-214%-$123.4M+52.1%-$257.4M-83.1%-$140.6M+26.2%
-47%-32.2pp-14.7%+19.4pp-34.2%-13.4pp-20.7%+6.9pp
$10.5M+275%$2.8M-3.4%$2.9M-9.4%$3.2M-51.5%
-$7.9M$0+100%-$4.8M$0-100%
-$395.1M-220%-$123.4M+52.9%-$262.2M-86.5%-$140.6M-146%
-$29.2M-849%$3.9M-$28.6M+4.3%
-$365.9M-187%-$127.3M+51.7%-$263.3M-135%-$112M-312%
-44.4%-29.2pp-15.2%+19.8pp-35%-18.4pp-16.5%-12.6pp
-$3.93-179%-$1.41+55.7%-$3.18-129%-$1.39-266%
-$333.5M-436%-$62.2M+68.2%-$195.5M-122%-$87.9M+31.2%
-40.4%-33.0pp-7.4%+18.5pp-26%-13.0pp-13%+5.5pp
-$387.2M-214%-$123.4M+52.1%-$257.4M-83.1%-$140.6M+26.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Myriad Genetics's revenue?
Myriad Genetics (MYGN) generated $829.0M in revenue over the trailing twelve months, down 0.3% year over year.
Is Myriad Genetics profitable?
Myriad Genetics is not currently profitable: it reported a net loss of $399.9M over the trailing twelve months, a -48.2% net margin.
What are Myriad Genetics's profit margins?
Gross margin is 70.0% and operating margin is -46.9%, with a -48.2% net margin.
What is Myriad Genetics's earnings per share?
Myriad Genetics's diluted EPS over the trailing twelve months is $-4.29.
Where does Myriad Genetics's income statement data come from?
Every line is extracted from Myriad Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.